No Detail Found!

Clinical Analysis of Five Cases of AIDS-related Non-Hodgkin Lymphoma

Author(s)
Shubo Zuo Department of Medical Oncology,Jilin Tumour Hospital,Changchun,Jilin Province,PR China.
Na Xu Department of Medical Oncology,Jilin Tumour Hospital,Changchun,Jilin Province,PR China.
Zhongkun Li Department of Medical Oncology,Jilin Tumour Hospital,Changchun,Jilin Province,PR China.
Na Li Department of Medical Oncology,Jilin Tumour Hospital,Changchun,Jilin Province,PR China.
Hong Xia Department of Medical Oncology,Jilin Tumour Hospital,Changchun,Jilin Province,PR China.
Hongtao Ren Department of Medical Oncology,Jilin Tumour Hospital,Changchun,Jilin Province,PR China.
Huizheng Bao Department of Medical Oncology,Jilin Tumour Hospital,Changchun,Jilin Province,PR China.
Abstract
Objective: Secondary malignancy is a major life-threatening complication facing patients afflicted with acquired immunodeficiency syndrome (AIDS). This study aimed to retrospectively review clinical features and treatment course of five patients with AIDS-associated non-Hodgkin lymphoma (A-NHL) in Jilin Tumor Hospital. Methods: Five A-NHL patients were retrospectively and consecutively hospitalized at our oncological unit between January 2012 and June 2014. All patients received pre-emptive highly active antiretroviral therapy (HAART) and chemotherapy, and were subsequently followed up at the outpatient clinic. All five patients were male, aged 27-53 years, and afflicted with A-NHL involving upper jaw, right inguinal region, right-side gingiva, mediastinum, or right-side neck. Histology showed diffuse large B-cell lymphoma (n = 3) or plasmablastic lymphoma (n = 2). Results: Two patients achieved complete remission after HAART and chemotherapy, whereas other three patients required a second-line treatment, with two achieving stable disease and one dying within a follow-up period of 0.5-2 years. Conclusion: The findings of the present study showed that A-NHL is a disease often diagnosed in the middle-to-late stages, with diverse clinical manifestations and short overall survival. In the cases reviewed in this study, HAART in combination with standard dose or high-dose chemotherapy, HAART and molecular targeted chemotherapy was administered, and these treatments proved to be effective for improving the prognosis of these patients. Moreover, the CD4+ cell count was important for determining the prognosis of patients.
Publication Details
Page(s) 1574-1579
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 32, Issue: 6, Year: 2016

Request the full text from PASTIC

Keywords
chemotherapy, Antiretroviral therapy, Non-Hodgkin lymphoma, Human immunodeficiency virus/acquired immunodeficiency syndrome
0

Citations

0

Downloads

98

Views